Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyRegional therapyVisceral SurgeryDiseaseBreast CancerFallopian Tube CarcinomaGastric CancerOvarian TumorPeritoneal Carcinomatosis, SecondarySubgroupEpCAM positiveICD10C16.-C16.0C50.-C56C57.0C78.6MeSHBreast NeoplasmsCarcinoma, Ovarian EpithelialFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal NeoplasmsStomach NeoplasmsSequenceAntineoplastic therapySubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%No. Substances12 RadiotherapySupportive therapySubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%ParacetamolSodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%ParacetamolSodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%ParacetamolSodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%ParacetamolSodium ThiosulfateNo. Substances35Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationFirst lineseveral possibleTherapy phaseintraoperativTherapy intentionpalliativeRisksAnemia Hb below 8g/dlDiarrheaDyspneaElectrolyte DisturbanceEmetogenicity (MASCC/ESMO)Increase AminotransferasesInfectionsLymphopeniaPainPyrexiaThromboembolic Event only studiesPublicationAuthorHeiss MMvan Driel WDiseaseNeudiagnostiziertes Ovarial-Ca, Eileiter-Ca oder Peritoneal-Ca, Stadium III mit neoadjuvanter Therapie, ECOG 0-2Peritonealkarzinose, sekundär, EpCAM positivOriginCologne-Merheim Medical Center, University of Witten-Herdecke, Cologne, GermanyDepartment of Gynecology, Netherlands Cancer Institute, AmsterdamProtocols in Revision 2 protocols foundCatumaxomab (10/20/50/150), Peritoneal Carcinomatosis, Secondary (PID3037 V1.0)HIPEC - Cisplatin 100, Ovarian ca (PID108 V2.1)
